UK NHS Launches Artificial Pancreas for Type 1 Diabetes Patients

The groundbreaking device aims to automate blood sugar and insulin management, marking a significant healthcare innovation.

The UK's NHS is rolling out an artificial pancreas, called the Hybrid Closed Loop system, to tens of thousands of type 1 diabetes patients.
This initiative, a world-first, aims to significantly automate blood sugar and insulin level management.
The device has shown success in pilot trials, improving disease management and potentially preventing life-threatening symptoms.
Eligible patients include children, pregnant women, and adults with type 1 diabetes who have an HbA1c of 58 mmol/mol (7.5%) or higher.
The rollout is expected to take five years and builds on the success of a 2022 trial involving 835 adults and children.